|
FY2023
12 months to Sep 30, 2023
|
|
|---|---|
| Cash flows from operating activities | |
| Net income (loss) | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Investment income received in Trust Account | |
| Change in operating assets and liabilities | |
| Accrued liabilities | |
| Prepaid Expenses | |
| Net cash used in operating activities | |
| Cash flows from investing activities | |
| Cash deposited in Trust Account | |
| Net cash used in investing activities | |
| Cash flows from financing activities | |
| Proceeds from note payable with related party | |
| Extinguishment of note payable with related party | |
| Payment of underwriting fee and other offering costs | |
| Proceeds from sale of Units in IPO, including over-allotment | |
| Proceeds from issuance of Founder shares | |
| Net cash provided by financing activities | |
| Net increase in cash | |
| Cash- beginning of the year | |
| Cash- end of the year | |
| Supplemental disclosure of noncash activities | |
| Reclassification of offering costs related to public shares | |
| Remeasurement adjustment on public shares subject to possible redemption |
Loading...
